New England Journal of Medicine Retracts Amgen Drug Trial Paper Over Data Integrity Concerns
The New England Journal of Medicine (NEJM) has retracted a significant clinical trial paper that provided key evidence for Amgen’s drug Tavneos. The retraction follows concerns that patient outcome data may have been manipulated and that some researchers involved in the study were not blinded to treatment assignments. The paper, which supported the efficacy of […]